Notably, while both DDOST and STT3A knockdown sensitized HCC cells to lenvatinib, DDOST depletion showed significantly greater sensitization efficacy than STT3A knockdown (Supplementary Fig. 10a, b). Here, STT3A is linked to hepatocellular carcinoma.